Home / Netherlands / Lakefront Biotherapeutics NV

Lakefront Biotherapeutics NV

No short position is open on this share today.

0.00% of the capital sold short

0 disclosing funds

689 disclosures on record

Evolution of the disclosed total

0%1%2%3%

Oct 2025Jan 2026Apr 2026Jul 2026

Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

Over the whole history, the total peaked at 5.00% on May 21, 2018. The shaded band matches the twelve months of the first chart.

July 31, 2015 today

Open positions

No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.

Follow by RSS

Get the moves on Lakefront Biotherapeutics NV by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

689 disclosures on record for this share.
Date	Fund	% of capital
May 25, 2021	Avidity Partners Management LP	0.67%
May 24, 2021	Millennium International Management LP	0.68%
May 21, 2021	Millennium International Management LP	0.53%
May 19, 2021	Avidity Partners Management LP	0.70%
May 14, 2021	AQR Capital Management, LLC	0.50%
April 14, 2021	Avidity Partners Management LP	0.64%
April 13, 2021	WorldQuant, LLC	0.47%
April 12, 2021	WorldQuant, LLC	0.50%
April 9, 2021	WorldQuant, LLC	0.49%
March 31, 2021	WorldQuant, LLC	0.51%
March 29, 2021	Avidity Partners Management LP	0.59%
March 25, 2021	Avidity Partners Management LP	0.68%
March 24, 2021	Avidity Partners Management LP	0.71%
March 9, 2021	WorldQuant, LLC	0.47%
March 2, 2021	Avidity Partners Management LP	0.61%
February 25, 2021	WorldQuant, LLC	0.57%
February 22, 2021	WorldQuant, LLC	0.65%
February 22, 2021	D. E. Shaw & Co., L.P.	0.49%
February 18, 2021	WorldQuant, LLC	0.52%
February 18, 2021	D. E. Shaw & Co., L.P.	0.50%
February 16, 2021	D. E. Shaw & Co., L.P.	0.49%
February 12, 2021	AQR Capital Management, LLC	0.36%
February 11, 2021	AQR Capital Management, LLC	0.50%
February 10, 2021	AQR Capital Management, LLC	0.49%
February 4, 2021	AQR Capital Management, LLC	0.50%
February 2, 2021	D. E. Shaw & Co., L.P.	0.59%
January 13, 2021	Avidity Partners Management LP	0.53%
December 31, 2020	D. E. Shaw & Co., L.P.	0.69%
November 2, 2020	D. E. Shaw & Co., L.P.	0.79%
October 2, 2020	D. E. Shaw & Co., L.P.	0.89%
September 18, 2020	Marshall Wace LLP	0.49%
September 16, 2020	D. E. Shaw & Co., L.P.	0.90%
September 14, 2020	Marshall Wace LLP	0.53%
September 11, 2020	Marshall Wace LLP	0.48%
September 7, 2020	Marshall Wace LLP	0.58%
September 7, 2020	WorldQuant, LLC	0.46%
September 4, 2020	Marshall Wace LLP	0.60%
September 3, 2020	D. E. Shaw & Co., L.P.	0.89%
September 2, 2020	WorldQuant, LLC	0.59%
August 25, 2020	WorldQuant, LLC	0.61%
August 21, 2020	WorldQuant, LLC	0.55%
August 20, 2020	D. E. Shaw & Co., L.P.	0.93%
August 19, 2020	D. E. Shaw & Co., L.P.	0.89%
August 17, 2020	Marshall Wace LLP	0.55%
August 14, 2020	Marshall Wace LLP	0.70%
August 14, 2020	Citadel Advisors LLC	0.46%
August 13, 2020	Marshall Wace LLP	0.69%
July 31, 2020	Marshall Wace LLP	0.78%
July 30, 2020	Marshall Wace LLP	0.84%
July 28, 2020	Marshall Wace LLP	0.90%

Download 689 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in the Netherlands

Akzo Nobel N.V. 9.86% of the capital sold short
Pharming Group N.V. 7.95% of the capital sold short
Signify N.V. 7.52% of the capital sold short
Imcd N.V. 4.65% of the capital sold short
Fugro N.V. 4.20% of the capital sold short
DSM-Firmenich AG 3.48% of the capital sold short
Basic-Fit N.V. 3.43% of the capital sold short
PostNL N.V. 2.55% of the capital sold short
NSI N.V. 2.01% of the capital sold short
Alfen N.V. 1.85% of the capital sold short
Arcadis N.V. 1.72% of the capital sold short
Sligro Food Group N.V. 1.55% of the capital sold short

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Lakefront Biotherapeutics NV, source AFM, data as at April 2, 2026, https://www.quivad.com/action/lakefront-biotherapeutics-nv?page=5